PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 121 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $2,669,000 | -0.7% | 282,701 | -35.5% | 0.01% | -14.3% |
Q4 2015 | $2,687,000 | +46.4% | 438,402 | +36.8% | 0.01% | +40.0% |
Q3 2015 | $1,835,000 | +6696.3% | 320,407 | +8885.1% | 0.01% | – |
Q2 2015 | $27,000 | +35.0% | 3,566 | +8.4% | 0.00% | – |
Q1 2015 | $20,000 | – | 3,290 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
IFP Advisors, Inc | 0 | $0 | 0.00% |
NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |